首页> 外文期刊>European respiratory review >New bronchoscopic treatment modalities for patients with chronic bronchitis
【24h】

New bronchoscopic treatment modalities for patients with chronic bronchitis

机译:慢性支气管炎患者的新支气管镜治疗方式

获取原文
获取外文期刊封面目录资料

摘要

Chronic bronchitis is a chronic, progressive disease that is difficult to treat. Despite much effort, patients remain highly symptomatic. Currently, a number of innovative bronchoscopic treatments for this disease are under investigation. Liquid nitrogen metered cryospray, bronchial rheoplasty and balloon desobstruction all aim to destroy the hyperplastic goblet cells and excess submucous glands using different strategies. These therapies are in an early phase of clinical research and larger randomised controlled trials are needed to confirm the pilot data available and to evaluate the treatment durability. The fourth technique, targeted lung denervation (TLD), aims to decrease the release of acetylcholine, which regulates smooth muscle tone and mucus production by ablating the parasympathetic nerves running alongside the main bronchi. Evaluation of this treatment is at a more advanced stage and promising effects on exacerbation frequency have been shown. However, confirmation of the benefit in improvement in chronic bronchitis symptoms is still needed.
机译:慢性支气管炎是一种慢性,渐进性疾病,难以治疗。尽管有很多努力,患者仍然具有高度症状。目前,对该疾病进行了许多创新的支气管镜治疗。液氮计量乳粥,支气管rheoplasty和气球展开展开旨在使用不同的策略来破坏增生脚玻璃细胞和过量粘附腺。这些疗法处于早期临床研究的阶段,并且需要更大的随机对照试验来确认可用的试验数据并评估治疗耐用性。第四种技术,靶向肺参复(TLD),旨在减少乙酰胆碱的释放,通过消除伴随着主要的支气管的副交感神经来调节平滑肌肉间调和粘液生产。对该处理的评估是在更高级的阶段,并且已经显示出对加油频率的有希望的影响。然而,仍然需要确认改善慢性支气管炎症状的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号